Macquarie Group’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-33,333	Closed	-$338K	–	1759
2024 Q4	$338K	Hold	33,333	–	–	﹤0.01%	1474
2024 Q3	$415K	Sell	33,333 -379	-1%	-$4.72K	﹤0.01%	1495
2024 Q2	$439K	Buy	33,712 +379	+1%	+$4.94K	﹤0.01%	1480
2024 Q1	$755K	Buy	33,333 +8,000	+32%	+$181K	﹤0.01%	1402
2023 Q4	$329K	Hold	25,333	–	–	﹤0.01%	1507
2023 Q3	$509K	Hold	25,333	–	–	﹤0.01%	1439
2023 Q2	$680K	Hold	25,333	–	–	﹤0.01%	1416
2023 Q1	$1.48M	Hold	25,333	–	–	﹤0.01%	1257
2022 Q4	$1.29M	Sell	25,333 -98	-0.4%	-$5K	﹤0.01%	1350
2022 Q3	$2.09M	Sell	25,431 -38	-0.1%	-$3.12K	﹤0.01%	1211
2022 Q2	$1.72M	Hold	25,469	–	–	﹤0.01%	1346
2022 Q1	$2.82K	Hold	25,469	–	–	﹤0.01%	1274
2021 Q4	$2.46M	Hold	25,469	–	–	﹤0.01%	1315
2021 Q3	$2.22M	Hold	25,469	–	–	﹤0.01%	1351
2021 Q2	$3.94M	Buy	25,469 +65	+0.3%	+$10.1K	﹤0.01%	1199
2021 Q1	$4.01M	Sell	25,404 -18	-0.1%	-$2.84K	0.01%	971
2020 Q4	$5.9M	Hold	25,422	–	–	0.01%	843
2020 Q3	$5.57M	Hold	25,422	–	–	0.01%	801
2020 Q2	$7.22M	Buy	25,422 +89	+0.4%	+$25.3K	0.01%	702
2020 Q1	$7.3M	Hold	25,333	–	–	0.02%	634
2019 Q4	$7.29M	Hold	25,333	–	–	0.01%	710
2019 Q3	$3.66M	Hold	25,333	–	–	0.01%	840
2019 Q2	$2.28M	Hold	25,333	–	–	﹤0.01%	983
2019 Q1	$2.22M	Sell	25,333 -20	-0.1%	-$1.75K	﹤0.01%	966
2018 Q4	$3.56M	Buy	25,353 +2,806	+12%	+$394K	0.01%	834
2018 Q3	$5.76M	Sell	22,547 -160	-0.7%	-$40.9K	0.01%	756
2018 Q2	$5.79M	Buy	+22,707	New	+$5.79M	0.01%	746
2018 Q1	–	Sell	-60	Closed	-$9K	–	2272
2017 Q4	$9K	Buy	+60	New	+$9K	﹤0.01%	2276